MedTrace Logo

Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and CPD

NCT03833531 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2023-06-07

No results posted yet for this study

Summary

The goal of PROSPER-C is to study effectiveness of ImRs compared to integrated SFT-ImRs in treatment-seeking, adult patients with comorbid PTSD and Cluster C Personality Disorder (CPD).

Conditions

  • Posttraumatic Stress Disorder (PTSD)
  • Avoidant Personality Disorder
  • Dependent Personality Disorder
  • Obsessive Compulsive Personality Disorder

Interventions

BEHAVIORAL

ImRS

ImRs is a PTSD treatment that specifically addresses the troubling memories of the traumatic event and the personal meaning of the event and consist of 12 to 18 sessions in maximum 6 months.

BEHAVIORAL

SFT

SFT is a treatment for personality disorders that takes at least one group-session per week, for the duration of one year.

Sponsors & Collaborators

  • Sinai Centrum, Arkin, The Netherlands

    collaborator UNKNOWN

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • Stichting Steunfonds Joodse Geestelijke Gezondheidszorg (SSF JGG)

    collaborator UNKNOWN

  • Ziekenhuis Amstelland

    collaborator OTHER

  • Meander Medisch Centrum

    collaborator OTHER

  • Arkin

    lead INDUSTRY

Principal Investigators

  • Kathleen Thomaes, MD/PhD · Sinai Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2023-01-09
Completion
2023-05-05

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03833531 on ClinicalTrials.gov